Integra LifeSciences Welcomes Mojdeh Poul as New CEO
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical technology sector, has announced a significant leadership change with the appointment of Mojdeh Poul as the new President and Chief Executive Officer. This transition, effective from January 6, 2025, will see Ms. Poul succeeding Jan De Witte, who will continue to lead the company until that date.
A Visionary Leader
Mojdeh Poul's arrival at Integra is marked by excitement and anticipation, as expressed by Stuart Essig, the Executive Chairman of the company. He highlighted her extensive experience in the global healthcare landscape, emphasizing her capability in business strategy, transformation, and leadership development. Essig is confident that Poul’s track record of success will help execute Integra’s strategic vision effectively.
Proven Industry Expertise
Most recently, Ms. Poul served as the Executive Vice President and Group President at 3M, where she oversaw the $8.5 billion Global Healthcare Business. Her responsibilities included research and development, manufacturing, and commercial operations, making her well-suited for the challenges ahead at Integra. Poul's leadership led to critical innovations within the healthcare portfolio at 3M, showcasing her talent in both strategic acquisitions and product development.
Corporate Governance and Leadership Philosophy
In her new role at Integra, Ms. Poul aims to drive operational excellence while focusing on quality compliance. She has expressed her commitment to maximizing Integra’s product portfolio and enhancing patient outcomes by partnering with the board and her teams. Poul's leadership philosophy centers on fostering high-performance teams capable of navigating complex environments to deliver exceptional results.
Jan De Witte's Legacy
Jan De Witte’s tenure at Integra has set a strong foundation for future growth. His focus on international expansion and integrating digital technology into the company’s offerings will leave a lasting legacy. During his leadership, De Witte played a critical role in strategic acquisitions, such as Surgical Innovation Associates, which added valuable product lines to Integra’s portfolio.
A Bright Future Ahead
With the transition on the horizon, Ms. Poul expresses gratitude for the opportunity to lead Integra. She acknowledges the dedication of the Integra team over the years and emphasizes the company's role as a pioneer in medical technology innovation. As she steps into this leadership role, her vision aligns with Integra’s mission to restore patients' lives through innovative products and advanced healthcare solutions.
Educational Background and Board Memberships
Ms. Poul's academic credentials are impressive, holding a bachelor's and master's degree in mechanical engineering from the University of Louisville and an MBA from the University of North Carolina at Chapel Hill. She also actively contributes to various boards, demonstrating her commitment to corporate governance and strategic guidance.
About Integra LifeSciences
Integra LifeSciences is dedicated to innovating surgical, neurologic, and regenerative care solutions to improve patient lives. Their commitment to excellence is reflected in their high-quality product portfolio. As the company progresses toward new milestones, it will continue to uphold its standards of care and innovation, ensuring a brighter future for both patients and healthcare providers.
Frequently Asked Questions
Who is the new CEO of Integra LifeSciences?
Mojdeh Poul has been appointed as the new President and Chief Executive Officer of Integra LifeSciences.
When will Mojdeh Poul assume her role?
Ms. Poul will officially assume her role on January 6, 2025.
What is Mojdeh Poul's previous experience?
Prior to joining Integra, Ms. Poul served as Executive Vice President and Group President for 3M's Global Healthcare Business.
Who is Jan De Witte?
Jan De Witte is the current President and Chief Executive Officer of Integra LifeSciences until Mojdeh Poul takes over in January 2025.
What is the mission of Integra LifeSciences?
Integra LifeSciences aims to restore patients' lives through innovative medical technologies and high-quality surgical solutions.
